Skip to main content
. 2021 Jan 25;40:41. doi: 10.1186/s13046-021-01844-7

Fig. 5.

Fig. 5

Overexpression of CBR3-AS1 promotes ADR resistance in vivo. a In vivo experimental design. b CBR3-AS1 expression in the transplanted tumors. c miR-25-3p expression in the transplanted tumors. d Live imaging experiments showing transplanted tumor cells. e Representative images of tumors at 5 weeks after subcutaneous transplantation when mice were euthanized. f Tumor growth curves of the respective groups. g Tumor mass of the respective groups. h JNK1 and MEK4 protein expression was measured in the respective groups by western blot. I IHC analysis of the expression levels of JNK1 and MEK4 in the respective groups. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001